文献速递消化道肿瘤放疗放疗物理与技术

社区放疗卫星网络胰腺SBRT项目的实施与质量改进

Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite network.
PubMed 文献 · Clin Transl Radiat Oncol · 2021-02-12

研究采用PDSA质量改进方法,在整合的社区放疗卫星网络中实施不可切除胰腺癌SBRT项目,包含多学科评估、靶区勾画前瞻性审查、计划前瞻性评估和患者结局监测等QA措施。2017至2020年连续治疗12例患者,中位随访27个月,中位生存13个月,中位局部无失败生存12个月,中位无进展生存6个月,无≥3级急性或晚期CTCAE v5毒性。

要点

  • PDSA方法可在社区放疗卫星网络成功实施胰腺SBRT项目。
  • 12例患者中位生存13个月,中位局部无失败生存12个月。
  • 无≥3级急性或晚期CTCAE v5毒性,安全性可接受。

核心结论

  • 在社区放疗卫星网络中结合多项前瞻性QA措施可成功实施胰腺SBRT项目,为安全扩大社区胰腺SBRT可及性奠定基础。

研究设计与样本

  • 2017年采用Plan-Do-Study-Act(PDSA)质量改进方法,在整合的社区放疗卫星网络中实施胰腺SBRT项目,并回顾性分析2017至2020年连续治疗患者的结局。

主要发现

  • 共纳入12例连续患者,中位随访27个月。
  • 自SBRT起中位生存13个月,中位局部无失败生存12个月,中位无进展生存6个月。
  • 无急性或晚期CTCAE v5≥3级毒性。

关键数值与推荐

  • 工作流程包含多学科评估、放疗靶区勾画前瞻性审查、放疗计划前瞻性评估和患者结局监测等前瞻性QA措施。

临床怎么用

  • 在社区卫星网络引入胰腺SBRT时,可采用PDSA质量改进框架并整合多学科评估、靶区与计划前瞻性审查及结局监测等QA措施。

局限性

  • 为单中心回顾性研究,样本量12例,中位随访27个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: With increasing interest in stereotactic body radiotherapy (SBRT) for unresectable pancreatic cancer, quality improvement (QI) initiatives to develop integrated clinical workflows are crucial to ensure quality assurance (QA) when introducing this challenging technique into radiation practices. MATERIALS/METHODS: In 2017, we used the Plan, Do, Study, Act (PDSA) QI methodology to implement a new pancreas SBRT program in an integrated community radiation oncology satellite. A unified integrated information technology infrastructure was used to virtually integrate the planned workflow into the community radiation oncology satellite network (P - Plan/D - Do). This workflow included multiple prospective quality assurance (QA) measures including multidisciplinary evaluation, prospective scrutiny of radiation target delineation, prospective radiation plan evaluation, and monitoring of patient outcomes. Institutional review board approval was obtained to retrospectively study and report outcomes of patients treated in this program (S - Study). RESULTS: There were 12 consecutive patients identified who were treated in this program from 2017 to 2020 with a median follow-up of 27 months. The median survival was 13 months, median local failure free survival was 12 months and median progression free survival was 6 months from SBRT. There were no acute or late Common Terminology Criteria for Adverse Effects (CTCAE) version 5 toxicities ≥ Grade 3. CONCLUSION: We report the successful implementation of a community pancreas SBRT program involving multiple prospective QA measures, providing the groundwork to safely expand access to pancreas SBRT in our community satellite network (A - Act).

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Augustyn A, Reed VI, Ahmad N, et al. Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite network. Clin Transl Radiat Oncol. 2021. PMID: 33665384. doi:10.1016/j.ctro.2021.02.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。